Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension

Eur Respir J. 2010 Nov;36(5):1209-11. doi: 10.1183/09031936.00052210.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Benzamides
  • Bone Marrow Cells / cytology
  • Hematopoietic Stem Cell Mobilization*
  • Hematopoietic Stem Cells / cytology
  • Hypertension, Pulmonary / drug therapy*
  • Hypoxia / drug therapy*
  • Imatinib Mesylate
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Piperazines / pharmacology*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-kit / antagonists & inhibitors*
  • Pyrimidines / pharmacology*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit